anti-Helicobacter pylori compounds (Mitsubishi Pharma)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameanti-Helicobacter pylori compounds (Mitsubishi Pharma)
Drug Alias Nameanti-H pylori compounds (Mitsubishi Pharma)
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHelicobacter pylori infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitsubishi Pharma Corp
Active IndicationsN/A
Inactive IndicationsHelicobacter pylori infection

Other Information

ATC CodeN/A
Related LinksN/A